Evidence map›Paper›PMID 31171770›Full record

ArticleNature communications2019

Cholinergic neural activity directs retinal layer-specific angiogenesis and blood retinal barrier formation.

G A Weiner, S H Shah, C M Angelopoulos, A B Bartakova, R S Pulido, A Murphy, E Nudleman, R Daneman, J L Goldberg

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

G A WeinerNeurosciences Graduate Program, University of California, San Diego, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-3651-5976
S H ShahNeurosciences Graduate Program, University of California, San Diego, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-6601-219X
C M AngelopoulosDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, 92037, USA.
A B BartakovaShiley Eye Institute, Department of Ophthalmology, University of California, San Diego, La Jolla, CA, 92037, USA.
R S PulidoDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, 92037, USA.
A MurphyDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-5222-9902
E NudlemanShiley Eye Institute, Department of Ophthalmology, University of California, San Diego, La Jolla, CA, 92037, USA.
R DanemanDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, 92037, USA. rdaneman@ucsd.edu.
J L GoldbergSpencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, 94303, USA.
University of California San Diego · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Alfredo Dubra · 2017 to 2026
$8.0M
Ophthalmology and Visual Sciences Career Development K12 ProgramK12EY024225 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2015 to 2025
$4.3M
Salk Institute for Biological Studies NINDS Center Core GrantP30NS072031 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI O'LEARY, DENNIS D · 2011 to 2015
$4.2M
Regulation of blood-brain barrier formation and function by EHDsR01NS091281 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DANEMAN, RICHARD · 2015 to 2019
$1.9M
Role of PDLIM1 in Retinal Vascular Leakage and ProliferationK08EY028999 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NUDLEMAN, ERIC D · 2018 to 2020
$713k
NEI NIH HHS K08 EY028999NEI NIH HHS K12 EY024225NEI NIH HHS P30 EY026877NIGMS NIH HHS T32 GM007752NINDS NIH HHS P30 NS072031NINDS NIH HHS R01 NS091281
6 · The paper itself

Abstract

Blood vessels in the central nervous system (CNS) develop unique features, but the contribution of CNS neurons to regulating those features is not fully understood. We report that inhibiting spontaneous cholinergic activity or reducing starburst amacrine cell numbers prevents invasion of endothelial cells into the deep layers of the retina and causes blood-retinal-barrier (BRB) dysfunction in mice. Vascular endothelial growth factor (VEGF), which drives angiogenesis, and Norrin, a Wnt ligand that induces BRB properties, are decreased after activity blockade. Exogenous VEGF restores vessel growth but not BRB function, whereas stabilizing beta-catenin in endothelial cells rescues BRB dysfunction but not vessel formation. We further identify that inhibiting cholinergic activity reduces angiogenesis during oxygen-induced retinopathy. Our findings demonstrate that neural activity lies upstream of VEGF and Norrin, coordinating angiogenesis and BRB formation. Neural activity originating from specific neural circuits may be a general mechanism for driving regional angiogenesis and barrier formation across CNS development.

Indexed as

Amacrine CellsAnimalsbeta CateninBlood-Retinal BarrierBridged Bicyclo Compounds, HeterocyclicCholinergic NeuronsEndothelial CellsEye ProteinsMiceNeovascularization, PhysiologicNerve Tissue ProteinsNicotinic AgonistsOxygenPyridinesRetinal DiseasesRetinal Ganglion Cellsbeta CateninBridged Bicyclo Compounds, HeterocyclicCTNNB1 protein, mouseepibatidineEye ProteinsNdph protein, mouseNerve Tissue ProteinsNicotinic AgonistsOxygenPyridinesTetrodotoxinVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID31171770
PMCPMC6554348
OpenAlexW2948803622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.